PCVX vs REGN: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Regeneron Pharmaceuticals Inc in 2026
PCVX
Vaxcyte Inc
—
REGN
Regeneron Pharmaceuticals Inc
$678.94
Key Metrics Comparison
| Metric | PCVX | REGN | Winner |
|---|---|---|---|
| Market Cap | $6.84B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PCVX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or REGN a better investment?
Comparing PCVX and REGN: Vaxcyte Inc has a market cap of $6.84B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and REGN?
PCVX (Vaxcyte Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or REGN?
Both PCVX and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PCVX or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PCVX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $6.84B for PCVX.
Should I buy PCVX or REGN in 2026?
Both PCVX and REGN have investment merit. PCVX trades at $N/A while REGN trades at $678.94. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and REGN stock?
Key differences: Market Cap ($6.84B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PCVX or REGN in 2026?
The choice between PCVX and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PCVX and REGN?
PCVX (Vaxcyte Inc) has a market cap of $6.84B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.